Cargando…

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells

Rotenone is a commercial pesticide commonly used to model Parkinson’s disease (PD) due to its ability to induce dopaminergic degeneration. Studies have confirmed that rotenone causes microglial activation, which seems to contribute to the toxic effects seen in rodent models. Pituitary adenylate cycl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broome, Sarah Thomas, Musumeci, Giuseppe, Castorina, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726775/ https://www.ncbi.nlm.nih.gov/pubmed/35199308 http://dx.doi.org/10.1007/s12031-022-01968-1

Ejemplares similares

PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
por: Karunia, Jocelyn, et al.
Publicado: (2021)

Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
por: Broome, Sarah Thomas, et al.
Publicado: (2023)

Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
por: Jansen, Margo I., et al.
Publicado: (2022)

Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
por: Lee, Jayden, et al.
Publicado: (2023)

Pro-Inflammatory and Pro-Apoptotic Effects of the Non-Protein Amino Acid L-Azetidine-2-Carboxylic Acid in BV2 Microglial Cells
por: Piper, Jordan Allan, et al.
Publicado: (2022)

Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells
por: Thomas Broome, Sarah, et al.
Publicado: (2021)

Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet
por: Mandwie, Mawj, et al.
Publicado: (2021)

The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
por: Thomas Broome, Sarah, et al.
Publicado: (2022)

Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
por: Musumeci, Giuseppe, et al.
Publicado: (2018)

Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
por: Withana, Minduli, et al.
Publicado: (2023)

Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice
por: Thomas Broome, Sarah, et al.
Publicado: (2022)

Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
por: Schytz, Henrik Winther, et al.
Publicado: (2010)

Signal Transduction by VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2022)

BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5α-Dihydroprogesterone and Pregnanolone Levels
por: Avallone, Rossella, et al.
Publicado: (2020)

Involvement of 5-lipoxygenase/cysteinyl leukotriene receptor 1 in rotenone- and MPP+-induced BV2 microglial activation
por: Wang, Yanfang, et al.
Publicado: (2012)

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
por: Lu, Jessica, et al.
Publicado: (2022)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021)

Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress
por: Cline, Daemon L., et al.
Publicado: (2018)

PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism
por: Vu, John P., et al.
Publicado: (2023)

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
por: Temerozo, Jairo R., et al.
Publicado: (2013)

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP
por: Liao, Chenyi, et al.
Publicado: (2021)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms
por: Ng, Stephanie Y. L., et al.
Publicado: (2012)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023)

Rotenone Directly Induces BV2 Cell Activation via the p38 MAPK Pathway
por: Gao, Feng, et al.
Publicado: (2013)

Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
por: Giunta, Salvatore, et al.
Publicado: (2015)

High glucose enhances lipopolysaccharide‐induced inflammation in cultured BV2 microglial cell line
por: Hung, Hao‐Chang, et al.
Publicado: (2022)

Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration
por: Woodley, Patricia K., et al.
Publicado: (2019)

Messenger RNA Gene Expression Screening of VIP and PACAP Neuropeptides and Their Endogenous Receptors in Ruminants
por: Hawley, Emma, et al.
Publicado: (2022)

Malaysian brown macroalga Padina australis mitigates lipopolysaccharide-stimulated neuroinflammation in BV2 microglial cells
por: Subermaniam, Kogilavani, et al.
Publicado: (2023)

Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation
por: Zhou, Fang, et al.
Publicado: (2008)

Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction
por: Yan, Xiang, et al.
Publicado: (2023)

Trimethyltin-Induced Microglial Activation via NADPH Oxidase and MAPKs Pathway in BV-2 Microglial Cells
por: Kim, Da Jung, et al.
Publicado: (2015)

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression
por: Maugeri, Grazia, et al.
Publicado: (2016)

Expression and significance of TIMP-3, PACAP and VIP in vaginal wall tissues of patients with stress urinary incontinence
por: Fan, Bo, et al.
Publicado: (2017)

The inhibitory effects of Orengedokuto on inducible PGE2 production in BV-2 microglial cells
por: Iwata, Yoshika, et al.
Publicado: (2021)

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021)

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP
por: Bensalma, Souheyla, et al.
Publicado: (2019)

Dopamine: an immune transmitter
por: Thomas Broome, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ajdoqh1fl04ge4pgfsugsdt5t